Surmodics, Inc. (SRDX) DCF Valuation

Surmodics, Inc. (SRDX) DCF Valuation

US | Healthcare | Medical - Devices | NASDAQ
Surmodics, Inc. (SRDX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Surmodics, Inc. (SRDX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Surmodics, Inc. (SRDX) DCF Calculator! Explore the latest Surmodics financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Surmodics, Inc. (SRDX).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 94.9 105.1 100.0 132.6 126.1 136.7 148.2 160.6 174.1 188.8
Revenue Growth, % 0 10.83 -4.93 32.65 -4.91 8.41 8.41 8.41 8.41 8.41
EBITDA 5.9 12.2 -12.2 15.2 1.2 4.9 5.3 5.8 6.3 6.8
EBITDA, % 6.26 11.58 -12.23 11.43 0.94227 3.6 3.6 3.6 3.6 3.6
Depreciation 7.5 8.3 9.7 9.2 8.7 10.7 11.7 12.6 13.7 14.8
Depreciation, % 7.92 7.92 9.68 6.92 6.9 7.86 7.86 7.86 7.86 7.86
EBIT -1.6 3.8 -21.9 6.0 -7.5 -5.8 -6.3 -6.9 -7.4 -8.1
EBIT, % -1.65 3.66 -21.91 4.51 -5.95 -4.27 -4.27 -4.27 -4.27 -4.27
Total Cash 61.1 38.9 19.0 45.4 40.1 51.0 55.2 59.9 64.9 70.4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 16.2 22.9 24.2 23.9 23.2
Account Receivables, % 17.05 21.79 24.21 18.03 18.37
Inventories 6.0 6.8 11.8 14.8 15.2 13.1 14.2 15.3 16.6 18.0
Inventories, % 6.29 6.43 11.82 11.19 12.03 9.55 9.55 9.55 9.55 9.55
Accounts Payable 1.5 1.8 3.1 3.0 .0 2.4 2.6 2.8 3.0 3.3
Accounts Payable, % 1.6 1.7 3.14 2.26 0 1.74 1.74 1.74 1.74 1.74
Capital Expenditure -3.7 -6.3 -3.4 -2.9 -3.5 -5.0 -5.4 -5.8 -6.3 -6.9
Capital Expenditure, % -3.87 -5.97 -3.37 -2.2 -2.77 -3.64 -3.64 -3.64 -3.64 -3.64
Tax Rate, % -53.77 -53.77 -53.77 -53.77 -53.77 -53.77 -53.77 -53.77 -53.77 -53.77
EBITAT 1.2 2.6 -26.5 -3.7 -11.5 -3.1 -3.4 -3.7 -4.0 -4.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -15.6 -2.7 -25.2 -.3 -8.9 3.1 -.3 -.3 -.3 -.4
WACC, % 9.55 9.95 10.15 9.55 10.15 9.87 9.87 9.87 9.87 9.87
PV UFCF
SUM PV UFCF 1.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value -5
Present Terminal Value -3
Enterprise Value -1
Net Debt -3
Equity Value 2
Diluted Shares Outstanding, MM 14
Equity Value Per Share 0.12

What You Will Get

  • Real SRDX Financial Data: Pre-filled with Surmodics, Inc.’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Surmodics, Inc.’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Surmodics, Inc. (SRDX).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to Surmodics, Inc. (SRDX).
  • Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates for accurate projections.
  • Integrated Financial Ratios: Assess profitability, leverage, and efficiency ratios relevant to Surmodics, Inc. (SRDX).
  • Interactive Dashboard and Charts: Visual representations highlight key valuation metrics for straightforward analysis.

How It Works

  • Download: Get the pre-prepared Excel file containing Surmodics, Inc.'s (SRDX) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and compare results immediately.
  • Make Decisions: Utilize the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for Surmodics, Inc. (SRDX)?

  • Accurate Data: Utilize real Surmodics financials for trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants focused on Surmodics.
  • User-Friendly: Easy-to-navigate design and clear instructions cater to users of all experience levels.

Who Should Use Surmodics, Inc. (SRDX)?

  • Healthcare Professionals: Understand the latest advancements in medical device technologies and their applications.
  • Researchers: Utilize data from Surmodics, Inc. (SRDX) to enhance studies in drug delivery systems.
  • Investors: Analyze market trends and evaluate investment opportunities related to Surmodics, Inc. (SRDX).
  • Business Analysts: Leverage customizable financial models to assess Surmodics, Inc. (SRDX) performance.
  • Medical Device Entrepreneurs: Gain insights into the strategies used by established companies like Surmodics, Inc. (SRDX).

What the Template Contains

  • Pre-Filled Data: Includes Surmodics, Inc.'s (SRDX) historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Surmodics, Inc.'s (SRDX) profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

Es wurden keine passenden Produkte gefunden.